Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $98.35 USD
Change Today -0.29 / -0.29%
Volume 1.5M
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David R. Epstein B.Sc., M.B.A.

Division Head of Novartis Pharmaceuticals,Novartis AG
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 6 different industries.

As of Fiscal Year 2014


Mr. David R. Epstein, B.Sc., M.B.A. has been Division Head of Novartis Pharmaceuticals at Novartis AG since 2010. Mr. Epstein serves as President of Novartis at Novartis Pharma K.K. He has been Head of Global Pharmaceuticals Division at Novartis AG and Novartis Vaccines and Diagnostics, Inc. since February 1, 2010. Mr. Epstein serves as President and Chief Executive Officer of Oncology and Molecular Diagnostics of Novartis Institutes for Biomedical Research, Inc. He ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056


Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


MBA 1987
Columbia Business School
BS 1984
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Total Annual Compensation$3,920,050

Stock Options*

Long Term Incentive Plan$3,780,003
All Other Compensation$621,264

Total Compensation*

Total Annual Cash Compensation$4,541,314
Total Short Term Compensation$3,920,050
Other Long Term Compensation$621,264
Total Calculated Compensation$8,321,317
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVS:US $98.35 USD -0.29


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Paul Bulcke B.E.Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee
Nestlé S.A.
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
Olivier Brandicourt Chief Executive Officer and Director
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-SPONSORED ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at